Logo image of BLZE

BACKBLAZE INC-A (BLZE) Stock Fundamental Analysis

NASDAQ:BLZE - Nasdaq - US05637B1052 - Common Stock - Currency: USD

7.21  -0.24 (-3.22%)

After market: 7.3 +0.09 (+1.25%)

Fundamental Rating

2

Overall BLZE gets a fundamental rating of 2 out of 10. We evaluated BLZE against 82 industry peers in the IT Services industry. Both the profitability and financial health of BLZE have multiple concerns. BLZE is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BLZE had negative earnings in the past year.
BLZE had a positive operating cash flow in the past year.
BLZE had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BLZE reported negative operating cash flow in multiple years.
BLZE Yearly Net Income VS EBIT VS OCF VS FCFBLZE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -20M -40M

1.2 Ratios

BLZE has a worse Return On Assets (-34.03%) than 84.62% of its industry peers.
BLZE has a worse Return On Equity (-108.24%) than 82.05% of its industry peers.
Industry RankSector Rank
ROA -34.03%
ROE -108.24%
ROIC N/A
ROA(3y)-30.77%
ROA(5y)-21.41%
ROE(3y)-76.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLZE Yearly ROA, ROE, ROICBLZE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -200 -400

1.3 Margins

BLZE's Gross Margin of 53.78% is fine compared to the rest of the industry. BLZE outperforms 75.64% of its industry peers.
BLZE's Gross Margin has declined in the last couple of years.
BLZE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.06%
GM growth 5YN/A
BLZE Yearly Profit, Operating, Gross MarginsBLZE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

BLZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BLZE has been increased compared to 1 year ago.
Compared to 1 year ago, BLZE has a worse debt to assets ratio.
BLZE Yearly Shares OutstandingBLZE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 10M 20M 30M
BLZE Yearly Total Debt VS Total AssetsBLZE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

BLZE has an Altman-Z score of 0.07. This is a bad value and indicates that BLZE is not financially healthy and even has some risk of bankruptcy.
BLZE has a worse Altman-Z score (0.07) than 82.05% of its industry peers.
BLZE has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
BLZE has a Debt to Equity ratio (0.39) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Altman-Z 0.07
ROIC/WACCN/A
WACC11.34%
BLZE Yearly LT Debt VS Equity VS FCFBLZE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.54 indicates that BLZE may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.54, BLZE is doing worse than 92.31% of the companies in the same industry.
A Quick Ratio of 0.54 indicates that BLZE may have some problems paying its short term obligations.
With a Quick ratio value of 0.54, BLZE is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54
BLZE Yearly Current Assets VS Current LiabilitesBLZE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

BLZE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.56%, which is quite impressive.
The Revenue has grown by 27.41% in the past year. This is a very strong growth!
The Revenue has been growing by 23.79% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)45.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.09%
Revenue 1Y (TTM)27.41%
Revenue growth 3Y23.79%
Revenue growth 5YN/A
Sales Q2Q%28.82%

3.2 Future

The Earnings Per Share is expected to grow by 18.99% on average over the next years. This is quite good.
Based on estimates for the next years, BLZE will show a very strong growth in Revenue. The Revenue will grow by 20.10% on average per year.
EPS Next Y35.18%
EPS Next 2Y24.23%
EPS Next 3Y18.99%
EPS Next 5YN/A
Revenue Next Year25.75%
Revenue Next 2Y20.1%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BLZE Yearly Revenue VS EstimatesBLZE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
BLZE Yearly EPS VS EstimatesBLZE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLZE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BLZE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLZE Price Earnings VS Forward Price EarningsBLZE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLZE Per share dataBLZE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as BLZE's earnings are expected to grow with 18.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.23%
EPS Next 3Y18.99%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BLZE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BACKBLAZE INC-A

NASDAQ:BLZE (2/21/2025, 8:03:48 PM)

After market: 7.3 +0.09 (+1.25%)

7.21

-0.24 (-3.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-25 2025-02-25/amc
Inst Owners38.23%
Inst Owner Change-78.76%
Ins Owners4.72%
Ins Owner Change-0.18%
Market Cap364.25M
Analysts85
Price Target12.83 (77.95%)
Short Float %1.31%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.78%
Min EPS beat(2)-17.65%
Max EPS beat(2)8.09%
EPS beat(4)3
Avg EPS beat(4)15.84%
Min EPS beat(4)-17.65%
Max EPS beat(4)52.4%
EPS beat(8)4
Avg EPS beat(8)4.56%
EPS beat(12)4
Avg EPS beat(12)-2.5%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.94%
Min Revenue beat(2)-1.5%
Max Revenue beat(2)-0.38%
Revenue beat(4)0
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-1.5%
Max Revenue beat(4)-0.1%
Revenue beat(8)0
Avg Revenue beat(8)-1%
Revenue beat(12)1
Avg Revenue beat(12)-0.71%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.72%
PT rev (3m)-6.02%
EPS NQ rev (1m)-5.8%
EPS NQ rev (3m)-5.8%
EPS NY rev (1m)0.54%
EPS NY rev (3m)-7.78%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.97
P/FCF N/A
P/OCF 26.94
P/B 8.5
P/tB 203.04
EV/EBITDA N/A
EPS(TTM)-0.98
EYN/A
EPS(NY)-0.75
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.27
OCFY3.71%
SpS2.43
BVpS0.85
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.03%
ROE -108.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.78%
FCFM N/A
ROA(3y)-30.77%
ROA(5y)-21.41%
ROE(3y)-76.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.06%
GM growth 5YN/A
F-Score5
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.66%
Cap/Sales 12.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z 0.07
F-Score5
WACC11.34%
ROIC/WACCN/A
Cap/Depr(3y)76.4%
Cap/Depr(5y)61.21%
Cap/Sales(3y)18.4%
Cap/Sales(5y)14.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.09%
EPS Next Y35.18%
EPS Next 2Y24.23%
EPS Next 3Y18.99%
EPS Next 5YN/A
Revenue 1Y (TTM)27.41%
Revenue growth 3Y23.79%
Revenue growth 5YN/A
Sales Q2Q%28.82%
Revenue Next Year25.75%
Revenue Next 2Y20.1%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year123.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y92.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y203.38%
OCF growth 3YN/A
OCF growth 5YN/A